Overview Performance Dividends Fundamentals Peer Group Correlations Pair Trades Institutions Insider Forecasts Options

Performance of RMD ResMed | -8.6% in 12m

Compare RMD with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?

Compare ResMed with its related Sector/Index XLV

Compare ResMed with its related Sector/Index XLV

Performance Duell RMD vs XLV

TimeFrame RMD XLV
1 Day 18.9% 0.03%
1 Week 20.9% 0.34%
1 Month 10.1% -5.26%
3 Months 14.3% 0.15%
6 Months 62.9% 14.58%
12 Months -8.57% 6.54%
YTD 27.3% 1.21%
Rel. Perf. 1m 0.74
Rel. Perf. 3m 1.35
Rel. Perf. 6m 2.46
Rel. Perf. 12m -1.78

Is ResMed a good stock to buy?

Yes, based on ValueRay Fundamental Analyses, ResMed (NYSE:RMD) is currently (April 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 76.78 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RMD as of April 2024 is 204.28. This means that RMD is currently overvalued and has a potential downside of -6.32% (Sold with Premium).

Is RMD a buy, sell or hold?

  • Strong Buy: 7
  • Buy: 3
  • Hold: 5
  • Sell: 1
  • Strong Sell: 0
ResMed has received a consensus analysts rating of 4.00. Therefor, it is recommend to buy RMD.
Values above 0%: RMD is performing better - Values below 0%: RMD is underperforming

Compare RMD with Broad Market Indices

Symbol 1w 1m 6m 12m
US S&P 500 SPY 19.20% 12.94% 38.22% -32.54%
US NASDAQ 100 QQQ 18.00% 13.04% 37.57% -43.08%
US Dow Jones Industrial 30 DIA 20.93% 13.94% 43.84% -22.84%
German DAX 40 DBXD 19.27% 12.00% 39.46% -21.96%
UK FTSE 100 ISFU 18.42% 9.08% 46.56% -15.02%
Shanghai Shenzhen CSI 300 CSI 300 19.46% 8.24% 60.97% 5.31%
Hongkong Hang Seng HSI 14.31% 7.34% 65.40% 11.51%
Japan Nikkei 225 EXX7 21.22% 18.32% 45.93% -26.14%
India NIFTY 50 INDA 20.08% 8.69% 41.08% -36.05%
Brasil Bovespa EWZ 19.20% 12.82% 53.75% -26.95%

RMD ResMed vs. Sectors

Symbol 1w 1m 6m 12m
Communication Services XLC 20.24% 12.01% 35.24% -43.56%
Consumer Discretionary XLY 17.74% 14.45% 44.81% -28.47%
Consumer Staples XLP 20.32% 11.12% 47.63% -9.04%
Energy XLE 20.75% 8.70% 47.73% -24.92%
Financial XLF 21.03% 13.20% 31.95% -33.83%
Health Care XLV 20.57% 15.37% 48.29% -15.11%
Industrial XLI 19.86% 12.73% 34.59% -33.29%
Materials XLB 20.38% 13.74% 42.16% -21.99%
Real Estate XLRE 20.11% 17.88% 48.19% -8.60%
Technology XLK 18.04% 14.16% 38.37% -42.13%
Utilities XLU 20.67% 9.29% 48.17% -7.83%
Aerospace & Defense XAR 18.47% 13.24% 41.19% -28.14%
Biotech XBI 21.22% 22.12% 32.64% -12.69%
Homebuilder XHB 18.15% 17.16% 13.70% -56.04%
Retail XRT 18.46% 17.41% 35.60% -29.49%

RMD ResMed vs. Commodities

Symbol 1w 1m 6m 12m
Oil USO 18.87% 8.00% 60.28% -27.67%
Natural Gas UNG 27.43% 13.61% 114.05% 41.29%
Gold GLD 20.42% 4.81% 46.50% -25.79%
Silver SLV 21.07% 0.70% 45.35% -16.79%
Copper CPER 19.34% -3.54% 36.88% -28.28%

Returns of RMD vs. Yields & Bonds

Symbol 1w 1m 6m 12m
iShares 20+ Years Bond TLT 21.76% 16.54% 56.22% 5.48%
iShares High Yield Corp. Bond HYG 20.62% 11.03% 53.69% -16.50%
Does ResMed outperform its market, is RMD a Sector Leader?
No, over the last 12 months ResMed (RMD) made -8.57%, while its related Sector, the Health Care Sector SPDR Fund (XLV) made 6.54%.
Over the last 3 months RMD made 14.32%, while XLV made 0.15%.
Period RMD XLV S&P 500
1 Month 10.11% -5.26% -2.83%
3 Months 14.32% 0.15% 3.78%
12 Months -8.57% 6.54% 23.97%